Sanitary Pad Mucosal Irritation Testing: Standards, Methods, and Compliance Guide

Mucosal irritation testing is an essential biocompatibility and biological safety evaluation for sanitary pads and other disposable hygiene products that come into prolonged contact with delicate vulvovaginal mucosal tissue. Conducted in accordance with internationally recognized standards such as ISO 10993-10 and its Chinese counterpart GB/T 16886.10, this testing determines whether a product or its extractable chemical substances can provoke irritation responses such as erythema, edema, or histopathological changes. This article provides a comprehensive technical overview of the testing principles, sample requirements, methodologies, and regulatory applications of sanitary pad mucosal irritation testing.

Technical Overview

Sanitary pads are disposable absorbent hygiene products designed for direct and prolonged contact with the vulvar and perineal mucosa during menstruation. A typical sanitary pad is a multilayer composite consisting of a nonwoven polymer topsheet, an absorbent core containing fluff pulp and superabsorbent polymer (SAP), a polyethylene backsheet, hot-melt adhesives, and sometimes fragrances, herbal extracts, or functional additives. Residual monomers, processing chemicals, dyes, preservatives, and additive residues may migrate from these materials onto mucosal tissue under the warm, moist, and occlusive conditions of actual use.

Mucosal irritation testing evaluates the biological safety of these products by assessing the local irritant potential of the finished product or its chemical extracts when applied to mucosal tissue. Because vaginal mucosa is thinner, more vascularized, and more permeable than intact skin, it is more susceptible to chemical insult, making irritation testing a non-negotiable element of product safety assurance.

The testing framework is primarily governed by the following standards:

• ISO 10993-10 – Biological evaluation of medical devices, Part 10: Tests for irritation and skin sensitization, which defines the intravaginal irritation test protocol.
• GB/T 16886.10 – The Chinese national standard adopted from ISO 10993-10, widely applied to hygiene and sanitary products in the Chinese market.
• GB 15979 – Hygienic standard for disposable sanitary products, which sets microbiological, physicochemical, and toxicological safety requirements, including mucosal irritation evaluation.
• GB/T 8939 – Specification for sanitary towels, covering dimensional, absorbency, and quality requirements for finished products.

Testing is typically performed by accredited third-party laboratories or in-house biological safety facilities operating under GLP-compliant quality management systems, with results documented in formal test reports used for product registration, market surveillance, and e-commerce platform compliance.

Testing Samples

Finished Products

Complete, commercially representative sanitary pads taken directly from production batches or retail packaging are tested in their final sterilized and sealed state. Testing the finished product captures the cumulative effect of all materials, adhesives, and any surface treatments, and it is the sample type most commonly requested for regulatory submission and market entry documentation.

Component and Raw Materials

Individual components may be tested separately during material screening and supplier qualification. This includes the nonwoven topsheet (typically polypropylene or polyethylene/polypropylene composite), the absorbent core materials, the polyethylene backsheet film, hot-melt adhesives, and functional additives such as negative-ion chips or plant extracts. Component-level testing helps isolate the source of any irritation response observed in the finished product.

Test Extracts

Because sanitary pads are not implantable and contact the mucosa as a solid article, testing is performed on aqueous and non-aqueous extracts rather than on the intact article. Standard practice involves preparing:

• Polar extract – typically 0.9% sodium chloride injection or sterile physiological saline, which extracts water-soluble irritants.
• Non-polar extract – typically refined sesame seed oil or cottonseed oil, which extracts lipophilic substances such as adhesive residues and plasticizer additives.
• Control extracts – the same media without the test article, processed identically, to serve as negative controls.

Testing Items

Depending on the product claims, intended use, and target market, the following biological and physicochemical items are commonly evaluated as part of a mucosal irritation safety package:

• Acute vaginal mucosal irritation test – a single-cycle exposure assessing the immediate irritant potential of product extracts on rabbit vaginal mucosa.
• Repeated-dose (subacute) vaginal irritation test – multiple consecutive exposures simulating prolonged or repeated product use, used for products with extended wear claims or medicated formulations.
• Skin irritation test – complementary evaluation for external skin-contact surfaces, often conducted using reconstructed human epidermis models in accordance with OECD Test Guideline 439.
• In vitro cytotoxicity screening – a preliminary biocompatibility assay per ISO 10993-5 used to identify toxic extractables before proceeding to animal-based testing.
• pH and physicochemical indices – pH measurement of the product extract, which supports mucosal compatibility assessment since healthy vaginal mucosa maintains an acidic pH of approximately 3.8 to 4.5.
• Histopathological examination – microscopic evaluation of vaginal tissue sections to confirm or rule out epithelial damage, inflammatory cell infiltration, and edema that may not be visible macroscopically.

Testing Methods

Sample Preparation and Extraction

The test article is cut into pieces and extracted in polar and non-polar media at a standardized surface-area-to-volume ratio, typically under conditions of 37°C for 24 hours, consistent with ISO 10993-12 extraction conventions. Extracts are prepared under aseptic or controlled conditions and used promptly to avoid degradation. The extraction ratio, temperature, and duration are documented in the test report because they directly influence the concentration of leachable substances introduced to the test system.

In Vivo Intravaginal Irritation Test

The reference method follows the intravaginal irritation test described in ISO 10993-10 and GB/T 16886.10. Healthy adult female rabbits are randomly assigned to test and control groups. A defined volume of the test extract is instilled into the vaginal canal, with the corresponding medium control administered contralaterally or to a parallel control group. After the exposure period, the vaginal mucosa is examined macroscopically and scored for erythema, edema, and discharge. The animals are then humanely euthanized, and vaginal tissues are harvested, fixed, sectioned, and stained for histopathological evaluation of epithelial integrity, leukocyte infiltration, and vascular congestion. The study is conducted under institutional animal ethics approval and the principles of the 3Rs (replacement, reduction, refinement).

In Vitro Alternative Methods

To progressively reduce animal use, reconstructed human vaginal epithelium models derived from three-dimensional cultured cells are increasingly applied as screening tools. Test extracts are applied to the apical surface of the tissue model, and irritancy is quantified by measuring cell viability using MTT or similar metabolic assays, supplemented by release of inflammatory markers such as IL-1α and IL-8. Positive and negative controls are run in parallel. These in vitro methods provide rapid, reproducible screening data and are valuable in early-stage material development, although in vivo testing remains the reference approach for many regulatory submissions.

Scoring and Result Interpretation

Results are expressed as an irritation index calculated from the difference between the mean macroscopic and histopathological scores of the test group and the corresponding control group. The test article is classified as a non-irritant, a mild irritant, a moderate irritant, or a severe irritant to mucous membranes based on the numeric index. A test is considered valid only when control animals show no significant irritation response. A passing result, in which the sample demonstrates no significant mucosal irritation compared with controls, supports the biological safety claim of the product.

Applications

Mucosal irritation test reports serve multiple commercial and regulatory purposes across the hygiene products industry:

• Market entry and product registration – supporting compliance documentation required for sanitary product licensing, filing, and market surveillance in regulated jurisdictions.
• E-commerce platform compliance – major online retail platforms require biological safety test reports, including mucosal irritation results, before approving sanitary pad listings.
• New product development – verifying the safety of new topsheet materials, functional additives, herbal or fragrance formulations, and alternative absorbent core chemistries prior to commercialization.
• Supplier and incoming material control – qualifying raw material suppliers and monitoring batch-to-batch consistency of nonwovens, adhesives, and superabsorbent polymers.
• Export support – providing biocompatibility evidence aligned with ISO 10993-10 that can be presented to overseas buyers, distributors, and regulatory authorities.
• Quality incident investigation – evaluating suspected adverse-event reports and defending product safety in consumer complaints or regulatory inquiries.

FAQ

What is the purpose of mucosal irritation testing for sanitary pads?

It determines whether chemical substances migrating from the product can cause local irritation to the vaginal or vulvar mucosa, which is more sensitive than skin. The test protects consumer health and provides documented evidence of biological safety for regulatory and commercial purposes.

Which standards apply to the testing?

The core methodology is defined by ISO 10993-10 and GB/T 16886.10 for the intravaginal irritation test, with supporting requirements from GB 15979 for disposable sanitary products and ISO 10993-12 for extract preparation. In vitro skin irritation screening may reference OECD Test Guideline 439.

How long does the test take?

A standard acute vaginal mucosal irritation test, including extraction, in-life observation, and histopathology, typically requires several weeks from sample receipt to final report. In vitro screening tests can be completed within one to two weeks, making them suitable for rapid material screening.

Can in vitro testing fully replace animal testing?

In vitro reconstructed epithelium models are excellent screening tools and are increasingly accepted, but the in vivo intravaginal test remains the reference method for many regulatory submissions. A combined strategy of in vitro screening followed by confirmatory in vivo testing where necessary is the current best practice.

What sample quantity is required?

Laboratories generally request a sufficient number of complete finished products, often dozens of pads from a single production batch, to prepare both polar and non-polar extracts at the required surface-area-to-volume ratio, along with retained samples for repeat testing if needed.

What result indicates the product is safe?

A test article is judged acceptable when the calculated irritation index shows no significant difference from the medium control, supported by histopathology confirming the absence of epithelial damage or inflammation. This non-irritant classification is the expected outcome for a compliant sanitary pad.